MEF2C Antikörper (pSer222)
-
- Target Alle MEF2C Antikörper anzeigen
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
-
Bindungsspezifität
- pSer222
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MEF2C Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Human
- Homologie
- bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
- Aufreinigung
- Antigen Affinity Purified from Pooled Serum
- Immunogen
- Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
- Top Product
- Discover our top product MEF2C Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 100 μL in 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
- Lagerung
- -20 °C
-
-
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
: "
-
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
- Target
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
- Andere Bezeichnung
- MEF2C (MEF2C Produkte)
- Molekulargewicht
- '51 kDa
- Gen-ID
- 4208
- UniProt
- Q06413
- Pathways
- Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
-